Antisense oligonucleotide compositions
US11859180B2 · kind B2 · utility
0Cited by
67References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 9, 2020 |
| Grant date | Jan 2, 2024 |
| Priority date | — |
| Expiry date | Jan 28, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2320/52
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides compositions comprising an antisense oligonucleotide and one or more excipients that modulates viscosity, turbidity or both viscosity and turbidity. In certain embodiments, compositions comprising an antisense oligonucleotide and one or more excipients having low viscosity are provided. In certain embodiments, compositions comprising an antisense oligonucleotide and one or more excipients having low turbidity are provided. In certain embodiments, pharmaceutical compositions comprising an antisense oligonucleotide and one or more excipients having low viscosity and turbidity are provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.